With over 4 million NGS patient test cases interpreted worldwide, QIAGEN’s trusted portfolio of clinical interpretation and reporting solutions delivers the molecular insight you need to make confident decisions for every patient, every time.
Going to ASHG 2024? Dr. David Bick of Genomics England talks why QCI Interpret was selcted for Newborn Genome Programme
Don't miss the opportunity to hear from Dr. David Bick as he shares how QCI Interpret is used throughout the UK to provide variant interpretation and reporting for WGS of 100,000 newborns.
Expert White Paper GenQA shows QCI Interpret exhibits higher consistency than human NGS variant interpretation at 8 labs
Study in the Journal of Molecular Pathology compares accuracy and consistency of QCI Interpret to manual variant interpretation methods of 8 laboratories.
